These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 15084115
21. New scaffolds for the design of selective estrogen receptor modulators. Martín-Santamaría S, Rodríguez JJ, de Pascual-Teresa S, Gordon S, Bengtsson M, Garrido-Laguna I, Rubio-Viqueira B, López-Casas PP, Hidalgo M, de Pascual-Teresa B, Ramos A. Org Biomol Chem; 2008 Oct 07; 6(19):3486-96. PubMed ID: 19082149 [Abstract] [Full Text] [Related]
22. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening. Shen J, Tan C, Zhang Y, Li X, Li W, Huang J, Shen X, Tang Y. J Med Chem; 2010 Jul 22; 53(14):5361-5. PubMed ID: 20553023 [Abstract] [Full Text] [Related]
23. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold. Richardson TI, Norman BH, Lugar CW, Jones SA, Wang Y, Durbin JD, Krishnan V, Dodge JA. Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3570-4. PubMed ID: 17485205 [Abstract] [Full Text] [Related]
24. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 3: synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification. Richardson TI, Dodge JA, Durst GL, Pfeifer LA, Shah J, Wang Y, Durbin JD, Krishnan V, Norman BH. Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4824-8. PubMed ID: 17614275 [Abstract] [Full Text] [Related]
25. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators. Guo ZR, Yi X, Xu ZB. Acta Pharmacol Sin; 2002 Mar 01; 23(3):208-12. PubMed ID: 11918843 [Abstract] [Full Text] [Related]
27. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α. Eignerová B, Sedlák D, Dracínský M, Bartunek P, Kotora M. J Med Chem; 2010 Oct 14; 53(19):6947-53. PubMed ID: 20812681 [Abstract] [Full Text] [Related]
33. ERbeta ligands. Part 5: synthesis and structure-activity relationships of a series of 4'-hydroxyphenyl-aryl-carbaldehyde oxime derivatives. Mewshaw RE, Bowen SM, Harris HA, Xu ZB, Manas ES, Cohn ST. Bioorg Med Chem Lett; 2007 Feb 15; 17(4):902-6. PubMed ID: 17188490 [Abstract] [Full Text] [Related]
35. Lessons learnt from structural studies of the oestrogen receptor. Pike AC. Best Pract Res Clin Endocrinol Metab; 2006 Mar 15; 20(1):1-14. PubMed ID: 16522516 [Abstract] [Full Text] [Related]
36. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. Jordan VC. J Med Chem; 2003 Mar 27; 46(7):1081-111. PubMed ID: 12646017 [No Abstract] [Full Text] [Related]
38. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity. Amari G, Armani E, Ghirardi S, Delcanale M, Civelli M, Caruso PL, Galbiati E, Lipreri M, Rivara S, Lodola A, Mor M. Bioorg Med Chem; 2004 Jul 15; 12(14):3763-82. PubMed ID: 15210143 [Abstract] [Full Text] [Related]
39. m-Carborane bisphenol structure as a pharmacophore for selective estrogen receptor modulators. Ogawa T, Ohta K, Yoshimi T, Yamazaki H, Suzuki T, Ohta S, Endo Y. Bioorg Med Chem Lett; 2006 Aug 01; 16(15):3943-6. PubMed ID: 16735120 [Abstract] [Full Text] [Related]